IHAM
Integral Health Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.9M | Buy |
55,000
+5,000
| +10% | +$1.63M | 1.64% | 19 |
|
|
2025
Q1 | $13.5M | Buy |
50,000
+5,000
| +11% | +$1.35M | 1.44% | 19 |
|
|
2024
Q4 | $10.6M | Buy |
45,000
+20,000
| +80% | +$4.71M | 0.9% | 41 |
|
|
2024
Q3 | $6.88M | Buy |
+25,000
| New | +$6.88M | 0.77% | 33 |
|
|
2024
Q2 | – | Sell |
-50,000
| Closed | -$7.47M | – | 74 |
|
|
2024
Q1 | $7.47M | Buy |
50,000
+5,000
| +11% | +$747K | 0.69% | 50 |
|
|
2023
Q4 | $8.61M | Buy |
+45,000
| New | +$8.61M | 1.17% | 37 |
|
|
2023
Q3 | – | Sell |
-52,000
| Closed | -$9.88M | – | 65 |
|
|
2023
Q2 | $9.88M | Buy |
52,000
+32,000
| +160% | +$6.08M | 1.22% | 33 |
|
|
2023
Q1 | $4.01M | Sell |
20,000
-15,000
| -43% | -$3M | 0.81% | 48 |
|
|
2022
Q4 | $8.32M | Sell |
35,000
-35,000
| -50% | -$8.32M | 1.75% | 22 |
|
|
2022
Q3 | $14M | Buy |
70,000
+23,034
| +49% | +$4.61M | 2.72% | 9 |
|
|
2022
Q2 | $6.85M | Buy |
+46,966
| New | +$6.85M | 1.41% | 25 |
|
|
2022
Q1 | – | Sell |
-20,000
| Closed | -$3.39M | – | 74 |
|
|
2021
Q4 | $3.39M | Sell |
20,000
-5,000
| -20% | -$848K | 0.94% | 34 |
|
|
2021
Q3 | $4.72M | Hold |
25,000
| – | – | 1.36% | 27 |
|
|
2021
Q2 | $4.24M | Sell |
25,000
-15,000
| -38% | -$2.54M | 1.17% | 35 |
|
|
2021
Q1 | $5.65M | Buy |
40,000
+25,000
| +167% | +$3.53M | 1.61% | 22 |
|
|
2020
Q4 | $1.95M | Sell |
15,000
-10,000
| -40% | -$1.3M | 0.58% | 46 |
|
|
2020
Q3 | $3.64M | Buy |
+25,000
| New | +$3.64M | 1.11% | 31 |
|